These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 401860)

  • 1. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.
    North RJ; Kirstein DP
    J Exp Med; 1977 Feb; 145(2):275-92. PubMed ID: 401860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity.
    Youdim
    Cancer Res; 1977 Apr; 37(4):991-6. PubMed ID: 403003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune response to syngeneic UV-induced tumors. III. Requirement for an Ia+ macrophage in the in vitro differentiation of cytotoxic T lymphocytes.
    Woodward JG; Fernandez PA; Daynes RA
    J Immunol; 1979 Apr; 122(4):1196-202. PubMed ID: 312833
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of PSK on the recovery of macrophage function and T cell-mediated immunity in tumor-bearing mice].
    Tsuru S; Taniguchi M; Zinnaka Y; Nomoto K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2375-80. PubMed ID: 6333849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity.
    Urban JL; Schreiber H
    J Exp Med; 1983 Feb; 157(2):642-56. PubMed ID: 6185615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity to bacterial infection in the mouse. Thymus-derived cells as effectors of acquired resistance to Listeria monocytogenes.
    Blanden RV; Langman RE
    Scand J Immunol; 1972; 1(4):379-91. PubMed ID: 4129963
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma.
    Bast RC; Zbar B; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):749-56. PubMed ID: 804566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression.
    North RJ
    Cancer Immunol Immunother; 1984; 18(2):75-9. PubMed ID: 6391656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis.
    North RJ
    Infect Immun; 1974 Jul; 10(1):66-71. PubMed ID: 4210333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity.
    North RJ; Kirstein DP; Tuttle RL
    J Exp Med; 1976 Mar; 143(3):574-84. PubMed ID: 1249521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage content of tumours in relation to metastatic spread and host immune reaction.
    Eccles SA; Alexander P
    Nature; 1974 Aug; 250(5468):667-9. PubMed ID: 4546859
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of sea star coelomocyte extract on cell-mediated resistance to Listeria monocytogenes in mice.
    Willenborg DO; Prendergast RA
    J Exp Med; 1974 Apr; 139(4):820-33. PubMed ID: 4205878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained effect of inhaled diesel exhaust particles on T-lymphocyte-mediated immune responses against Listeria monocytogenes.
    Yin XJ; Dong CC; Ma JY; Antonini JM; Roberts JR; Barger MW; Ma JK
    Toxicol Sci; 2005 Nov; 88(1):73-81. PubMed ID: 16107554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
    Svoboda I; Măzuran R; Rabatić S; Silobrcić
    Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of effector T lymphocytes against a tumor allograft by T lymphocytes sensitized in vitro.
    Treves AJ; Cohen IR
    J Natl Cancer Inst; 1973 Dec; 51(6):1919-25. PubMed ID: 4543604
    [No Abstract]   [Full Text] [Related]  

  • 17. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES
    J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thymectomy on tumor development and on T and B lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1979; 26(4):413-21. PubMed ID: 392324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity.
    Berche P; Gaillard JL; Sansonetti PJ
    J Immunol; 1987 Apr; 138(7):2266-71. PubMed ID: 3104455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.
    North RJ
    Cancer Immunol Immunother; 1984; 18(2):69-74. PubMed ID: 6334549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.